Jeil Fatless Injection (L-Carnitine)

Adult administration

1. Primary and secondary carnitine deficiency Myocardial metabolic disorder due to ischemic heart disease: angina pectoris, acute myocardial infarction Adults: Administer 2~3 g of L-carnitine daily in 2~3 divided doses by intramuscular or intravenous injection. Adjust the dose as appropriate according to age and symptoms. 2. Treatment of carnitine deficiency in patients with end-stage renal disease undergoing hemodialysis Initially, administer 10~20 mg/kg intravenously over 2~3 minutes at the end of each hemodialysis session. However, the dose may be adjusted according to the plasma L-carnitine level before hemodialysis.

When using ampoule containers made of glass, care must be taken as glass fragments may mix in when cutting the container. Extra caution is needed when administering to children and the elderly. This medication should not be used in patients with an allergic reaction to it. Temporary nausea or vomiting may occur during use, and rarely changes in body odor or gastritis may appear. Additionally, in patients with a history of seizures, seizures may occur more frequently or worsen, so caution is required. Various side effects have been reported in chronic dialysis patients, including abdominal pain, allergic reactions, headaches, infections, and pain at the injection site. Cardiovascular issues such as arrhythmias or blood pressure changes may occur, and gastrointestinal issues like loss of appetite, diarrhea, nausea, and vomiting may appear. Furthermore, various side effects have been reported in multiple systems including the blood and lymphatic system, endocrine system, musculoskeletal system, nervous system, respiratory system, and skin system, hence if any abnormal symptoms arise, medical consultation should be sought immediately. The safety of this medication during pregnancy has not been established, so it should only be used in pregnant women or women who are possibly pregnant if the benefits of treatment are deemed greater than the risks. It is unknown how much of this medication is excreted in breast milk during breastfeeding, but since most medications can be transmitted through breast milk, it should be used cautiously.

• Temporary zones
• vomiting
• body odor
• gastritis
• seizures
• abdominal pain
• accidental injury
• allergic reactions
• asthma
• back pain

This medication should be stored in a sealed container that blocks light, at a temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage maintains the efficacy and safety of the medication.

Appearance

A clear colorless to pale yellow liquid contained in a brown transparent glass ampoule.

Package unit

5 mL/ampoule X 25 ampoules